American Gastroenterological Association - Advancing the Science and Practice of Gastroenterology

HCV Patient Care for the Non-Hepatologist: Management of Chronic HCV in the Era of Protease Inhibitors

With an increasing demand for HCV care in the U.S.and not enough hepatologists to meet this demand — especially outside of larger metropolitan areas — general practce gastroenterologists are needed to help fill the gap. This webinar is intended to help  enhance their ability to effectively and efficiently treat most HCV-positive patients.

It will also be valuable to all clinicians since it addresses the changes in treatment and expected outcomes of the direct-acting drugs telapravir and boceprevir. Additional topics to be covered, but not limited to, will include:

• Epidemiology and natural history of HCV infection.
• Screening and diagnosis of HCV, including genotypes and implications for treatment.
• Selecting and dosing treatment options.
• Identifying and managing treatment side effects and assessing treatment success.
• Treatment failures.
• Cost-efficient patient management.
• Co-morbidities.

This webinar is part two of a two-part series. Click here to view the first webinar.

Target Audience

Gastroenterologists, physician assistants, nurse practitioners, trainees

Course Director and Faculty

Course Director

Vinod K. Rustgi, MD
Medical Director, Liver Transplantation
Metropolitan Liver Diseases/Gastroenterology Center
Fairfax, VA

Faculty

Faculty Disclosures

Stuart C. Gordon - Advisory Committees or Review Panels: Merck & Co, Gilead Sciences Inc; Consulting: Achillion Pharmaceutical, CVS-Caremark; Speaking and Teaching: Merck & Co, Gilead Sciences Inc, Vertex Pharmaceuticals

Additional Information

For for questions related to the webinar, contact Sandra Megally at smegally@gastro.org.